Table 4. Platelet Count (103/μL) in treated children.

	Treated children, No.	Baseline	After 12 Wk	After 24 Wk	End of Treatment
		IFN + RBV (n = 119)
SVR a	62	268 ± 66 b	221 ± 57 b	236 ± 66	261 ± 78
Treatment-naïve	53	267 ± 62	220 ± 57	235 ± 66	255 ± 79
Retherapy	9	273 ± 86	229 ± 61	243 ± 66	289 ± 71
NR a	57	269 ± 77 b	215±62 b	217 ± 61 b	258 ± 86
Treatment-naïve	48	272 ± 76	217 ± 61	221 ± 61	261 ± 90
Retherapy	9	254 ± 80	205 ± 66	203 ± 64	229 ± 50
		Peg-IFN-α-2b + RBV (n = 51)
SVR	24	245 ± 65 b	172 ± 45 b	181 ± 55	215 ± 64
Treatment-naïve	15	244 ± 72	166 ± 46	171 ± 60	190 ± 50
Retherapy	9	246 ± 55	182 ± 45	196 ± 44	247 ± 69
NR	27	277 ± 70 b	198±45 b	204 ± 50	234 ± 45
Treatment-naïve	10	247 ± 48	182 ± 47	194 ± 49	215 ± 37
Retherapy	17	295 ± 77	208 ± 42	209 ± 51	244 ± 46

^a Abbreviations: nR; non-responders, SVR; Sustained virological response

^b Statistically significant difference, P < 0.05 (time dependent in one group)